Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Coronavirus Notebook: UK Begins COVID-19 Vaccine Rollout, Government May Enlist Military Backup

Executive Summary

EU passes legislation allowing VAT exemption for coronavirus vaccines to make them more affordable, as two treatments for severe disease and “Long COVID” respectively enter Phase II trials.

You may also be interested in...



Digitalization Key To Sustaining COVID-Related Boost To UK Supplements Market

Thanks to coronavirus-related wellness trends, the UK's vitamins and mineral supplementns market is set to be worth $664m by the end of the year, according to Mintel. But to make sure this increased demand is here to stay, consumer health companies need to leverage the power of digital to help consumers establish long-term supplementation habits into the future. 

New Coronavirus Variant May Have Implications For Vaccine Composition

Close monitoring of the effectiveness of coronavirus vaccines will be necessary after a new variant of SARS-CoV-2 was reported to be causing a rapid increase in transmission of the virus in the UK. The pharmaceutical industry says companies are not expecting travel restrictions imposed on the UK to have an impact on the supply of medicines.

Brexit: Companies Must ‘Act Now’ To Avoid Drug Supply Disruptions In 2021

In its latest letter to medicines and medical product companies, the UK's Department of Health and Social Care says the biggest potential cause of disruption to supplies could be failure to prepare for border controls implemented by the EU member states after the end of the Brexit transition period.

Topics

Related Companies

UsernamePublicRestriction

Register

PS143411

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel